Role of PKCδ in insulin sensitivity and skeletal muscle metabolism

Diabetes

Volumn 64, Issue 12, 2015, Pages 4023-4032

  Li, Mengyao ^a   Vienberg, Sara G ^a,b   Bezy, Olivier ^a   O'Neill, Brian T ^a   Kahn, C Ronald ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b Capital Region   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN; PROTEIN KINASE C DELTA; GLUCOSE BLOOD LEVEL; RECOMBINANT PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY COMPOSITION; CONTROLLED STUDY; ENERGY EXPENDITURE; EXERCISE; GENE EXPRESSION; GLUCOSE METABOLISM; GLUCOSE TOLERANCE TEST; GRIP STRENGTH TEST; HYPERINSULINEMIC-EUGLYCEMIC CLAMP TECHNIQUE; INSULIN RESISTANCE; INSULIN SENSITIVITY; INSULIN TOLERANCE TEST; METABOLIC RATE; MOUSE; MUSCLE CELL; MUSCLE METABOLISM; NONHUMAN; OXYGEN CONSUMPTION; PRIORITY JOURNAL; RESPIRATION CONTROL; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; ADVERSE EFFECTS; AGING; ANALYSIS; ANIMAL; BLOOD; COMPARATIVE STUDY; ENERGY METABOLISM; ENZYME INDUCTION; ENZYME REPRESSION; ENZYMOLOGY; GENETICS; GLUCOSE BLOOD LEVEL; GLUCOSE INTOLERANCE; GROWTH, DEVELOPMENT AND AGING; KNOCKOUT MOUSE; LIPID DIET; METABOLISM; MITOCHONDRIAL DYNAMICS; MUSCLE DEVELOPMENT; MUSCLE MITOCHONDRION; OBESITY; PATHOLOGY; TRANSGENIC MOUSE;

ADIPOSITY; AGING; ANIMALS; BLOOD GLUCOSE; DIET, HIGH-FAT; ENERGY METABOLISM; ENZYME INDUCTION; ENZYME REPRESSION; GLUCOSE INTOLERANCE; INSULIN; INSULIN RESISTANCE; MICE, KNOCKOUT; MICE, TRANSGENIC; MITOCHONDRIA, MUSCLE; MITOCHONDRIAL DYNAMICS; MUSCLE DEVELOPMENT; MUSCLE, SKELETAL; OBESITY; PROTEIN KINASE C-DELTA; RECOMBINANT PROTEINS;

EID: 84946796497     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db14-1891     Document Type: Article

References (43)

1. Brand C, Horovitz-Fried M, Inbar A, Tamar-Brutman-Barazani, Brodie C, Sampson SR. Insulin stimulation of PKCd triggers its rapid degradation via the ubiquitin-proteasome pathway. Biochim Biophys Acta 2010;1803:1265-1275
2. Turban S, Hajduch E. Protein kinase C isoforms: mediators of reactive lipid metabolites in the development of insulin resistance. FEBS Letters 2011;585: 269-274
3. Schmitz-Peiffer C, Biden TJ. Protein kinase C function in muscle, liver, and β-cells and its therapeutic implications for type 2 diabetes. Diabetes 2008;57: 1774-1783
4. Jacob AI, Horovitz-Fried M, Aga-Mizrachi S, et al. The regulatory domain of protein kinase C delta positively regulates insulin receptor signaling. J Mol Endocrinol 2010;44:155-169
5. Braiman L, Alt A, Kuroki T, et al. Protein kinase Cdelta mediates insulin-induced glucose transport in primary cultures of rat skeletal muscle. Mol Endocrinol 1999;13:2002-2012
6. Schmitz-Peiffer C. Signalling aspects of insulin resistance in skeletal muscle: mechanisms induced by lipid oversupply. Cell Signal 2000;12:583-594
7. Schmitz-Peiffer C. Protein kinase C and lipid-induced insulin resistance in skeletal muscle. Ann N Y Acad Sci 2002;967:146-157
8. Itani SI, Ruderman NB, Schmieder F, Boden G. Lipid-induced insulin resistance in human muscle is associated with changes in diacylglycerol, protein kinase C, and IkappaB-alpha. Diabetes 2002;51:2005-2011
9. Griffin ME, Marcucci MJ, Cline GW, et al. Free fatty acid-induced insulin resistance is associated with activation of protein kinase C theta and alterations in the insulin signaling cascade. Diabetes 1999;48:1270-1274
10. Ishii H, Koya D, King GL. Protein kinase C activation and its role in the development of vascular complications in diabetes mellitus. J Mol Med (Berl) 1998;76:21-31
11. Xia P, Aiello LP, Ishii H, et al. Characterization of vascular endothelial growth factor's effect on the activation of protein kinase C, its isoforms, and endothelial cell growth. J Clin Invest 1996;98:2018-2026
12. Kim J, Koyanagi T, Mochly-Rosen D. PKCd activation mediates angiogen-esis via NADPH oxidase activity in PC-3 prostate cancer cells. Prostate 2011;71: 946-954
13. Kellerer M, Mushack J, Seffer E, Mischak H, Ullrich A, Häring HU. Protein kinase C isoforms alpha, delta and theta require insulin receptor substrate-1 to inhibit the tyrosine kinase activity of the insulin receptor in human kidney embryonic cells (HEK 293 cells). Diabetologia 1998;41:833-838
14. Greene MW, Burrington CM, Luo Y, Ruhoff MS, Lynch DT, Chaithongdi N. PKCd is activated in the liver of obese Zucker rats and mediates diet-induced whole body insulin resistance and hepatocyte cellular insulin resistance. J Nutr Biochem 2014;25:281-288
15. Almind K, Kahn CR. Genetic determinants of energy expenditure and insulin resistance in diet-induced obesity in mice. Diabetes 2004;53:3274-3285
16. Zhang J, Burrington CM, Davenport SK, et al. PKCd regulates hepatic triglyceride accumulation and insulin signaling in Lepr(db/db) mice. Biochem Bio-phys Res Commun 2014;450:1619-1625
17. Bezy O, Tran TT, Pihlajamäki J, et al. PKCd regulates hepatic insulin sensitivity and hepatosteatosis in mice and humans. J Clin Invest 2011;121:2504-2517
18. DeFronzo RA, Tripathy D. Skeletal muscle insulin resistance is the primary defect in type 2 diabetes. Diabetes Care 2009;32(Suppl. 2):S157-S163
19. Koonen DP, Sung MM, Kao CK, et al. Alterations in skeletal muscle fatty acid handling predisposes middle-aged mice to diet-induced insulin resistance. Diabetes 2010;59:1366-1375
20. Cheng A, Morsch M, Murata Y, Ghazanfari N, Reddel SW, Phillips WD. Sequence of age-associated changes to the mouse neuromuscular junction and the protective effects of voluntary exercise. PLoS One 2013;8:e67970
21. Brüning JC, Michael MD, Winnay JN, et al. A muscle-specific insulin receptor knockout exhibits features of the metabolic syndrome of NIDDM without altering glucose tolerance. Mol Cell 1998;2:559-569
22. Mansouri A, Muller FL, Liu Y, et al. Alterations in mitochondrial function, hydrogen peroxide release and oxidative damage in mouse hind-limb skeletal muscle during aging. Mech Ageing Dev 2006;127:298-306
23. Norris AW, Chen L, Fisher SJ, et al. Muscle-specific PPARgamma-deficient mice develop increased adiposity and insulin resistance but respond to thiazolidinediones. J Clin Invest 2003;112:608-618
24. Hayashi T, Hirshman MF, Kurth EJ, Winder WW, Goodyear LJ. Evidence for 59 AMP-activated protein kinase mediation of the effect of muscle contraction on glucose transport. Diabetes 1998;47:1369-1373
25. Fujii N, Jessen N, Goodyear LJ. AMP-activated protein kinase and the regulation of glucose transport. Am J Physiol Endocrinol Metab 2006;291:E867-E877
26. Fewell JG, Osinska H, Klevitsky R, et al. A treadmill exercise regimen for identifying cardiovascular phenotypes in transgenic mice. Am J Physiol 1997; 273:H1595-H1605
27. Nalbandian A, Nguyen C, Katheria V, et al. Exercise training reverses skeletal muscle atrophy in an experimental model of VCP disease. PLoS One 2013;8:e76187
28. Park YW, Zhu S, Palaniappan L, Heshka S, Carnethon MR, Heymsfield SB. The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994. Arch Intern Med 2003;163:427-436
29. Johnson JE, Wold BJ, Hauschka SD. Muscle creatine kinase sequence elements regulating skeletal and cardiac muscle expression in transgenic mice. Mol Cell Biol 1989;9:3393-3399
30. Azzi A, Boscoboinik D, Hensey C. The protein kinase C family. Eur J Biochem 1992;208:547-557
31. Braiman L, Alt A, Kuroki T, et al. Insulin induces specific interaction between insulin receptor and protein kinase C delta in primary cultured skeletal muscle. Mol Endocrinol 2001;15:565-574
32. Heled Y, Shapiro Y, Shani Y, et al. Physical exercise enhances protein kinase C delta activity and insulin receptor tyrosine phosphorylation in diabetes-prone psammomys obesus. Metabolism 2003;52:1028-1033
33. Heled Y, Shapiro Y, Shani Y, et al. Physical exercise prevents the development of type 2 diabetes mellitus in Psammomys obesus. Am J Physiol En-docrinol Metab 2002;282:E370-E375
34. Kim JK, Michael MD, Previs SF, et al. Redistribution of substrates to adipose tissue promotes obesity in mice with selective insulin resistance in muscle. J Clin Invest 2000;105:1791-1797
35. Kanthasamy AG, Kitazawa M, Kanthasamy A, Anantharam V. Role of pro-teolytic activation of protein kinase Cdelta in oxidative stress-induced apoptosis. Antioxid Redox Signal 2003;5:609-620
36. Yamaguchi T, Miki Y, Yoshida K. Protein kinase C delta activates IkappaB-kinase alpha to induce the p53 tumor suppressor in response to oxidative stress. Cell Signal 2007;19:2088-2097
37. Basu A. Involvement of protein kinase C-delta in DNA damage-induced apoptosis. J Cell Mol Med 2003;7:341-350
38. Mayr M, Chung YL, Mayr U, et al. Loss of PKC-delta alters cardiac metabolism. Am J Physiol Heart Circ Physiol 2004;287:H937-H945
39. Lee CF, Chen YC, Liu CY, Wei YH. Involvement of protein kinase C delta in the alteration of mitochondrial mass in human cells under oxidative stress. Free Radic Biol Med 2006;40:2136-2146
40. Kikkawa U, Matsuzaki H, Yamamoto T. Protein kinase C delta (PKC delta): activation mechanisms and functions. J Biochem 2002;132:831-839
41. Schmitz-Peiffer C, Browne CL, Oakes ND, et al. Alterations in the expression and cellular localization of protein kinase C isozymes epsilon and theta are associated with insulin resistance in skeletal muscle of the high-fat-fed rat. Diabetes 1997;46:169-178
42. Qu X, Seale JP, Donnelly R. Tissue and isoform-selective activation of protein kinase C in insulin-resistant obese Zucker rats - effects of feeding. J Endocrinol 1999;162:207-214
43. Ikeda Y, Olsen GS, Ziv E, et al. Cellular mechanism of nutritionally induced insulin resistance in Psammomys obesus: overexpression of protein kinase Cepsilon in skeletal muscle precedes the onset of hyperinsulinemia and hyper-glycemia. Diabetes 2001;50:584-592